{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:27:45Z","timestamp":1790681265272,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Portuguese Science and Technology Foundation","doi-asserted-by":"publisher","award":["PTDC\/SAU-GMG\/101874\/2008"],"award-info":[{"award-number":["PTDC\/SAU-GMG\/101874\/2008"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Spanish Ministry of Economy and Competitiveness","award":["BFU 2012-36241"],"award-info":[{"award-number":["BFU 2012-36241"]}]},{"DOI":"10.13039\/501100003086","name":"Basque Government","doi-asserted-by":"publisher","award":["IT849-13"],"award-info":[{"award-number":["IT849-13"]}],"id":[{"id":"10.13039\/501100003086","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003260","name":"PIF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003260","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.atherosclerosis.2018.06.819","type":"journal-article","created":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T13:46:17Z","timestamp":1538142377000},"page":"448-456","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Further evidence of novel APOB mutations as a cause of familial hypercholesterolaemia"],"prefix":"10.1016","volume":"277","author":[{"given":"Ana Catarina","family":"Alves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asier","family":"Benito-Vicente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Margarida","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaajal","family":"Reeves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mafalda","family":"Bourbon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"80","key":"10.1016\/j.atherosclerosis.2018.06.819_bib1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1126\/science.3513311","article-title":"A\u00a0receptor-mediated pathway for cholesterol homeostasis","volume":"232","author":"Brown","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2018.06.819_bib2","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1016\/j.jacc.2016.03.520","article-title":"Diagnostic yield and clinical utility of sequencing familial hypercholesterolemia genes in patients with severe hypercholesterolemia","volume":"67","author":"Khera","year":"2016","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2018.06.819_bib3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/MOL.0000000000000072","article-title":"Hypobetalipoproteinemia and abetalipoproteinemia","volume":"25","author":"Welty","year":"2014","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2018.06.819_bib4","article-title":"Analysis of publicly available LDLR, APOB, and PCSK9 variants associated with familial hypercholesterolemia: application of ACMG guidelines and implications for familial hypercholesterolemia diagnosis","author":"Chora","year":"2017","journal-title":"Genet. Med."},{"key":"10.1016\/j.atherosclerosis.2018.06.819_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0021-9150(93)90171-P","article-title":"Familial defective apolipoprotein B-100: a review, including some comparisons with familial hypercholesterolaemia","volume":"104","author":"Myant","year":"1993","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2018.06.819_bib6","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/eurheartj\/ehs010","article-title":"Advances in genetics show the need for extending screening strategies for autosomal dominant hypercholesterolaemia","volume":"33","author":"Motazacker","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2018.06.819_bib7","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1093\/hmg\/ddt573","article-title":"Novel functional APOB mutations outside LDL-binding region causing familial hypercholesterolaemia","volume":"23","author":"Alves","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.atherosclerosis.2018.06.819_bib8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/mgg3.17","article-title":"Identification and biochemical analysis of a novel APOB mutation that causes autosomal dominant hypercholesterolemia","volume":"1","author":"Thomas","year":"2013","journal-title":"Mol. Genet. Genomic Med."},{"key":"10.1016\/j.atherosclerosis.2018.06.819_bib9","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ng1161","article-title":"Mutations in PCSK9 cause autossomal dominant hypercholesterolemia","volume":"34","author":"Abifadel","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.atherosclerosis.2018.06.819_bib10","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/humu.20882","article-title":"Mutations and polymorphisms in the proprotein convertase subtilisin kexin 9 (PCSK9) gene in cholesterol metabolism and disease","volume":"30","author":"Abifadel","year":"2009","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.atherosclerosis.2018.06.819_bib11","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1194\/jlr.M028563","article-title":"Molecular characterization of proprotein convertase subtilisin\/kexin type 9-mediated degradation of the LDLR","volume":"53","author":"Wang","year":"2012","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2018.06.819_bib12","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/ncpcardio0836","article-title":"Mechanisms of disease: genetic causes of familial hypercholesterolemia","volume":"4","author":"Soutar","year":"2007","journal-title":"Nat. Clin. Pract. Cardiovasc. Med."},{"key":"10.1016\/j.atherosclerosis.2018.06.819_bib13","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.jacc.2015.08.871","article-title":"Characterization of the first PCSK9 gain of function homozygote","volume":"66","author":"Alves","year":"2015","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2018.06.819_bib14","doi-asserted-by":"crossref","first-page":"337","DOI":"10.33549\/physiolres.930000.50.337","article-title":"Major apolipoprotein B-100 mutations in lipoprotein metabolism and atherosclerosis","volume":"50","author":"Vrabl\u00edk","year":"2001","journal-title":"Physiol. Res."},{"key":"10.1016\/j.atherosclerosis.2018.06.819_bib15","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0022-2275(20)40068-9","article-title":"Mutations in the low density lipoprotein receptor gene of familial hypercholesterolemic patients detected by denaturing gradient gel electrophoresis and direct sequencing","volume":"36","author":"Lombardi","year":"1995","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2018.06.819_bib16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.atherosclerosis.2011.12.021","article-title":"Molecular characterization of familial hypercholesterolemia in Spain","volume":"221","author":"Palacios","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2018.06.819_bib17","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1399-0004.2009.01356.x","article-title":"Mutation detection rate and spectrum in familial hypercholesterolaemia patients in the UK pilot cascade project","volume":"77","author":"Taylor","year":"2010","journal-title":"Clin. Genet."},{"key":"10.1016\/j.atherosclerosis.2018.06.819_bib18","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s12471-011-0076-6","article-title":"Founder mutations in The Netherlands: geographical distribution of the most prevalent mutations in the low-density lipoprotein receptor and apolipoprotein B genes","volume":"19","author":"Kusters","year":"2011","journal-title":"Neth. Heart J."},{"key":"10.1016\/j.atherosclerosis.2018.06.819_bib19","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12881-015-0230-x","article-title":"Next-generation-sequencing-based identification of familial hypercholesterolemia-related mutations in subjects with increased LDL-C levels in a Latvian population","volume":"16","author":"Radovica-Spalvina","year":"2015","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.atherosclerosis.2018.06.819_bib20","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.atherosclerosis.2016.08.037","article-title":"Clinical characterization and mutation spectrum of German patients with familial hypercholesterolemia","volume":"253","author":"Grenkowitz","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2018.06.819_bib21","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1136\/jmedgenet-2012-101189","article-title":"Use of targeted exome sequencing as a diagnostic tool for Familial Hypercholesterolaemia","volume":"49","author":"Futema","year":"2012","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.atherosclerosis.2018.06.819_bib22","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1194\/jlr.D079301","article-title":"Use of next-generation sequencing to detect LDLR gene copy number variation in familial hypercholesterolemia","volume":"58","author":"Iacocca","year":"2017","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2018.06.819_bib23","doi-asserted-by":"crossref","DOI":"10.1194\/jlr.D045963","article-title":"LipidSeq: a next-generation clinical resequencing panel for monogenic dyslipidemias","author":"Johansen","year":"2014","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2018.06.819_bib24","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.atherosclerosis.2007.07.019","article-title":"Familial hypercholesterolaemia in Portugal","volume":"196","author":"Bourbon","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2018.06.819_bib25","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.atherosclerosis.2010.07.012","article-title":"Update of the Portuguese familial hypercholesterolaemia study","volume":"212","author":"Medeiros","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2018.06.819_bib26","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/gim.2015.71","article-title":"Mutational analysis of a cohort with clinical diagnosis of familial hypercholesterolemia: considerations for genetic diagnosis improvement","volume":"18","author":"Medeiros","year":"2016","journal-title":"Genet. Med."},{"key":"10.1016\/j.atherosclerosis.2018.06.819_bib27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/(SICI)1098-1004(200001)15:1<7::AID-HUMU4>3.0.CO;2-N","article-title":"Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion","volume":"15","author":"den Dunnen","year":"2000","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.atherosclerosis.2018.06.819_bib28","series-title":"Agilent High Sensitivity D1000 ScreenTape Assay Quick Guide for 4200 TapeStation System","author":"Agilent Technologies","year":"2017"},{"key":"10.1016\/j.atherosclerosis.2018.06.819_bib29","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A\u00a0method and server for predicting damaging missense mutations","volume":"7","author":"Adzhubei","year":"2010","journal-title":"Nat. Methods"},{"key":"10.1016\/j.atherosclerosis.2018.06.819_bib30","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1093\/nar\/gkg509","article-title":"SIFT: predicting amino acid changes that affect protein function","volume":"31","author":"Ng","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.atherosclerosis.2018.06.819_bib31","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nmeth0810-575","article-title":"MutationTaster evaluates disease-causing potential of sequence alterations","volume":"7","author":"Schwarz","year":"2010","journal-title":"Nat. Methods"},{"key":"10.1016\/j.atherosclerosis.2018.06.819_bib32","doi-asserted-by":"crossref","first-page":"W285","DOI":"10.1093\/nar\/gkm407","article-title":"SplicePort\u2013an interactive splice-site analysis tool","volume":"35","author":"Dogan","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.atherosclerosis.2018.06.819_bib33","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/cmb.1997.4.311","article-title":"Improved splice site detection in Genie","volume":"4","author":"Reese","year":"1997","journal-title":"J.\u00a0Comput. Biol."},{"key":"10.1016\/j.atherosclerosis.2018.06.819_bib34","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1093\/nar\/24.17.3439","article-title":"Splice site prediction in Arabidopsis thaliana pre-mRNA by combining local and global sequence information","volume":"24","author":"Hebsgaard","year":"1996","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.atherosclerosis.2018.06.819_bib35","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the american College of medical genetics and Genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"10.1016\/j.atherosclerosis.2018.06.819_bib36","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nature11632","article-title":"An integrated map of genetic variation from 1,092 human genomes","volume":"491","author":"Abecasis","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2018.06.819_bib37","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0022-2275(20)42758-0","article-title":"Low density lipoprotein-induced growth of U937 cells: a novel method to determine the receptor binding of low density lipoprotein","volume":"31","author":"Frosteg\u00e5rd","year":"1990","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2018.06.819_bib38","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/humu.21630","article-title":"Functional characterization of splicing and ligand-binding domain variants in the LDL receptor","volume":"33","author":"Etxebarria","year":"2012","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.atherosclerosis.2018.06.819_bib39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.atherosclerosis.2011.06.028","article-title":"ESC\/EAS guidelines for the management of dyslipidaemias the task force for the management of dyslipidaemias of the european society of Cardiology (ESC) and the european atherosclerosis society (EAS)","volume":"217","author":"Catapano","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2018.06.819_bib40","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1194\/jlr.M200470-JLR200","article-title":"Identification and characterization of LDL receptor gene mutations in hyperlipidemic Chinese","volume":"44","author":"Chang","year":"2003","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2018.06.819_bib41","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2018.06.819_bib42","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/s00439-001-0628-8","article-title":"The molecular basis of familial hypercholesterolemia in The Netherlands","volume":"109","author":"Fouchier","year":"2001","journal-title":"Hum. Genet."},{"key":"10.1016\/j.atherosclerosis.2018.06.819_bib43","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/jmedgenet-2014-102405","article-title":"Whole exome sequencing of familial hypercholesterolaemia patients negative for LDLR\/APOB\/PCSK9 mutations","volume":"51","author":"Futema","year":"2014","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.atherosclerosis.2018.06.819_bib44","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.atherosclerosis.2017.04.002","article-title":"Mutational analysis and genotype-phenotype relation in familial hypercholesterolemia: the SAFEHEART registry","volume":"262","author":"Bourbon","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2018.06.819_bib45","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.jacl.2016.04.006","article-title":"Clinical and molecular characteristics of homozygous familial hypercholesterolemia patients: insights from SAFEHEART registry","volume":"10","author":"Alonso","year":"2016","journal-title":"J.\u00a0Clin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2018.06.819_bib46","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jacl.2016.11.004","article-title":"Ibero-american familial hypercholesterolemia Network, clinical and molecular aspects of familial hypercholesterolemia in ibero-american countries","volume":"11","author":"Santos","year":"2017","journal-title":"J.\u00a0Clin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2018.06.819_bib47","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/iub.299","article-title":"Rare genetic causes of autosomal dominant or recessive hypercholesterolaemia","volume":"62","author":"Soutar","year":"2010","journal-title":"IUBMB Life"},{"key":"10.1016\/j.atherosclerosis.2018.06.819_bib48","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1161\/CIRCGENETICS.114.000776","article-title":"Exome sequencing in suspected monogenic dyslipidemias","volume":"8","author":"Stitziel","year":"2015","journal-title":"Circ. Cardiovasc. Genet."},{"key":"10.1016\/j.atherosclerosis.2018.06.819_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112677","article-title":"Advantages and versatility of fluorescence-based methodology to characterize the functionality of LDLR and class mutation assignment","volume":"9","author":"Etxebarria","year":"2014","journal-title":"PLoS One"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915018311328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915018311328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T21:34:41Z","timestamp":1720647281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915018311328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":49,"alternative-id":["S0021915018311328"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.06.819","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Further evidence of novel APOB mutations as a cause of familial hypercholesterolaemia","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.06.819","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}